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Validating Pre-regulatory 
Cost Estimates for the 
Revised Arsenic MCL
Patrick Gurian, Robin Bucciarelli-
Tieger, Mariana Chew, Alfredo 
Martinez, and Arturo Woocay
Background
• For decades EPA sought to revise the 50 
µg/l Maximum Contaminant Level (MCL) 
for arsenic
• In 2001 the MCL was lowered to 10 µg/l
• Enforceable as of January 2006
• Uncertainty and controversy 
– health effects
– compliance costs
Retrospective
• Now that the rule is established
• Can we resolve any of these 
controversies?
– Learn and improve the process
Sources of controversy:  Health 
risks
• Risk based on epidemiological studies in 
Taiwan
• Exposures of > 100 µg/l
• Health risk from arsenic at low levels 
found in U.S.
– Reduction of dozens of bladder cancers out of 
over 50,000 cases of bladder cancer annually 
(http://cpmcnet.columbia.edu/texts/gcps/gcps0027.html)
– We will not feasibly be able to resolve this 
uncertainty 
Sources of controversy:  Costs
• Several pre-regulatory studies of impacts
– EPA 2001
– Frey et al. 2000 (AWWARF-sponsored, 
independent)
– Gurian et al. 2001 (EPA-sponsored, 
independent)
• They all disagreed
Pre-regulatory cost estimates 
conflict
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Cost discrepancies
• These cost discrepancies are potentially 
resolvable after the implementation of the 
new MCL
• It is beginning to be possible to do this
– Survey utilities
– EPA pilot systems program
• Preliminary study
Survey
• Student survey in Fall of 2003
• Present results for six utilities for which 
Frey et al. (2000) conducted detailed pre-
regulatory analyses
– Industry leaders:  substantial progress toward 
meeting standard by 2003
– Only specific utilities for which we found 
detailed pre-regulatory studies
Why focus on Frey et al.?
• No disrespect is intended
• Control for large inter-system variability by 
comparing pre- and post-regulatory costs 
at the same systems
• Other studies (Gurian et al., EPA) 
modeled idealized systems
Survey results
• 5 out of 6 case study utilities provided information 
on capital costs
• Information on the 6th from website
• 4 out of six provided information on operations and 
maintenance (O&M) costs
• Thanks!
• One expressed concern about giving details of 
budgeted costs so we present results anonymously 
and numbering of utilities is not consistent
Capital costs
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Compliance approach
Utility
Number Survey Frey et al.
1 source switching C/MF
2 coagulation-filtration and iron-based media C/MF
3 source switching ion exchange
4 blending C/MF
5 blending C/MF
6 iron-based media and blending
activated 
alumina
Treatment Technology
Results of comparison
• Discrepancies observed
– Capital
– O&M
– Compliance method
• Note that Gurian et al. made similar 
predictions
– Predicted conventional filtration for large 
plants
Why the discrepancies?
• Overestimates tended to result when non-treatment 
(source switching or blending) options were available
– Pre-regulatory assumption that large systems would not find 
sufficient alternate resources
• Costs at the one utility that did treat rather than blend or 
switch were substantially underestimated
– Arsenic concentrations are variable and additional wells were 
treated to provide safety factor
– Pumping and piping costs were substantial,  27% of pre-
regulatory cost estimate
• Large (ground water) utilities are an aggregation of many 
sources and facilities
Small system treatment costs
• Post-regulatory:  Chen et al. (2004) capital 
costs from EPA pilot systems program
– Mostly iron-based adsorptive media
• Pre-regulatory EPA Technologies and 
Costs for Removal of Arsenic from 
Drinking Water (SAIC and Malcolm Pirnie, 
1999)
– Ion exchange
– Activated alumina
Capital Cost Comparison
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Small system treatment results
• In 10 out of 12 cases pilot site capital costs were 
below 1999 estimates
• A random sample would probably have included 
utilities using alternative sources, regionalizing, 
blending, etc. which would further lower average 
costs
• However, operational costs often dominate for 
small systems
• The nightmare scenario of small systems 
operating complex residual treatment systems 
does not seem to have materialized, perhaps 
partly because of iron-based adsorbents
Conclusions
• Can we learn anything from such a small survey?
• Yes:  Gurian et al. were wrong
– On costs, Gurian et al. also addressed national exposure 
assessment methodological issues, novel regulatory strategies
• Two separate errors
– Missed technological change: iron-based adsorbents
– Missed extent to which large systems (particularly large ground 
water systems) are an aggregation of small systems:  missed 
opportunities to switch sources
• Warrants further study to improve modeling for future 
regulations
– Need to validate disaggregated models
Benefits of following compliance 
behavior
• Learn how to improve regulatory impact 
models
• Identify most promising compliance 
strategies in reality
• What’s the best way to do this?
